Tuberculosis Testing and Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064664
  • May 2021
  • Medical Devices
  • 119 Pages
The Tuberculosis Testing and Diagnostics Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Alere Inc., F.Hoffmann-La Roche AG, Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Siemens, Hologic Corporation, Cepheid, Hain Lifesciences GmbH
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Tuberculosis Testing and Diagnostics market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Tuberculosis Testing and Diagnostics market is expected to attain Pre COVID-19 levels by mid-2022.

Tuberculosis Testing and Diagnostics Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Tuberculosis Testing and Diagnostics market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Tuberculosis Testing and Diagnostics Market Competitive and Premeditated Analysis
In the Tuberculosis Testing and Diagnostics report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Tuberculosis Testing and Diagnostics research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Tuberculosis Testing and Diagnostics Market:
The Tuberculosis Testing and Diagnostics market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Alere Inc., F.Hoffmann-La Roche AG, Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Siemens, Hologic Corporation, Cepheid, Hain Lifesciences GmbH

The Tuberculosis Testing and Diagnostics market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Tuberculosis Testing and Diagnostics Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Tuberculosis Testing and Diagnostics market:
By Test Type
Radiographic Method
Cytokine Detection Assay
Nucleic Acid Testing
Detection of Latent Infection
Diagnostic Laboratory Method
Detection of Drug Resistance
Others
End Use
Clinics
Hospitals
Research Institutes and Academics
Reference Laboratories
Others


Regional Analysis of the Tuberculosis Testing and Diagnostics market:
The Tuberculosis Testing and Diagnostics market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Tuberculosis Testing and Diagnostics report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Tuberculosis Testing and Diagnostics market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Tuberculosis Testing and Diagnostics market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Tuberculosis Testing and Diagnostics market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Tuberculosis Testing and Diagnostics market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Tuberculosis Testing and Diagnostics market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Tuberculosis Testing and Diagnostics market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Tuberculosis Testing and Diagnostics market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Tuberculosis Testing and Diagnostics market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Alere Inc.
  • F.Hoffmann-La Roche AG
  • Abbott Laboratories
  • Becton
  • Dickinson and Company
  • bioMérieux SA
  • Siemens
  • Hologic Corporation
  • Cepheid
  • Hain Lifesciences GmbH
  • Radiographic Method
  • Cytokine Detection Assay
  • Nucleic Acid Testing
  • Detection of Latent Infection
  • Diagnostic Laboratory Method
  • Detection of Drug Resistance
  • Others
  • Clinics
  • Hospitals
  • Research Institutes and Academics
  • Reference Laboratories
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Tuberculosis Testing and Diagnostics Market Snapshot
          2.1.1. Global Tuberculosis Testing and Diagnostics Market By Test Type,2019
               2.1.1.1.Radiographic Method
               2.1.1.2.Cytokine Detection Assay
               2.1.1.3.Nucleic Acid Testing
               2.1.1.4.Detection of Latent Infection
               2.1.1.5.Diagnostic Laboratory Method
               2.1.1.6.Detection of Drug Resistance
               2.1.1.7.Others
          2.1.2. Global Tuberculosis Testing and Diagnostics Market By End Use,2019
               2.1.2.1.Clinics
               2.1.2.2.Hospitals
               2.1.2.3.Research Institutes and Academics
               2.1.2.4.Reference Laboratories
               2.1.2.5.Others
          2.1.3. Global Tuberculosis Testing and Diagnostics Market By End-use,2019
          2.1.4. Global Tuberculosis Testing and Diagnostics Market By Geography,2019

3. Global Tuberculosis Testing and Diagnostics Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Tuberculosis Testing and Diagnostics Market Size (US$), By Test Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Test Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Test Type, 2020
     4.2. Global Tuberculosis Testing and Diagnostics Market Size (US$), By Test Type, 2018 – 2028

5. Global Tuberculosis Testing and Diagnostics Market Size (US$), By End Use, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End Use, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End Use, 2020
     5.2. Global Tuberculosis Testing and Diagnostics Market Size (US$), By End Use, 2018 – 2028

6. Global Tuberculosis Testing and Diagnostics Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Tuberculosis Testing and Diagnostics Market Size (US$), By End-use, 2018 – 2028

7. Global Tuberculosis Testing and Diagnostics Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Tuberculosis Testing and Diagnostics Market Analysis, 2018 – 2028 
          7.2.1. North America Tuberculosis Testing and Diagnostics Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Tuberculosis Testing and Diagnostics Market Size (US$), By Test Type, 2018 – 2028
          7.2.3. North America Tuberculosis Testing and Diagnostics Market Size (US$), By End Use, 2018 – 2028
          7.2.4. North America Tuberculosis Testing and Diagnostics Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Tuberculosis Testing and Diagnostics Market Analysis, 2018 – 2028 
          7.3.1.  Europe Tuberculosis Testing and Diagnostics Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Tuberculosis Testing and Diagnostics Market Size (US$), By Test Type, 2018 – 2028
          7.3.3. Europe Tuberculosis Testing and Diagnostics Market Size (US$), By End Use, 2018 – 2028
          7.3.4. Europe Tuberculosis Testing and Diagnostics Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Tuberculosis Testing and Diagnostics Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Tuberculosis Testing and Diagnostics Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Tuberculosis Testing and Diagnostics Market Size (US$), By Test Type, 2018 – 2028
          7.4.3. Asia Pacific Tuberculosis Testing and Diagnostics Market Size (US$), By End Use, 2018 – 2028
          7.4.4. Asia Pacific Tuberculosis Testing and Diagnostics Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Tuberculosis Testing and Diagnostics Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Tuberculosis Testing and Diagnostics Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Tuberculosis Testing and Diagnostics Market Size (US$), By Test Type, 2018 – 2028
          7.5.3. Latin America Tuberculosis Testing and Diagnostics Market Size (US$), By End Use, 2018 – 2028
          7.5.4. Latin America Tuberculosis Testing and Diagnostics Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Tuberculosis Testing and Diagnostics Market Analysis, 2018 – 2028 
          7.6.1.  MEA Tuberculosis Testing and Diagnostics Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Tuberculosis Testing and Diagnostics Market Size (US$), By Test Type, 2018 – 2028
          7.6.3. MEA Tuberculosis Testing and Diagnostics Market Size (US$), By End Use, 2018 – 2028
          7.6.4. MEA Tuberculosis Testing and Diagnostics Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Tuberculosis Testing and Diagnostics Providers
        8.4.1 Alere Inc.
                8.4.1.1 Business Description
                8.4.1.2 Alere Inc. Geographic Operations
                8.4.1.3 Alere Inc. Financial Information
                8.4.1.4 Alere Inc. Product Positions/Portfolio
                8.4.1.5 Alere Inc. Key Developments
        8.4.2 F.Hoffmann-La Roche AG
                8.4.2.1 Business Description
                8.4.2.2 F.Hoffmann-La Roche AG Geographic Operations
                8.4.2.3 F.Hoffmann-La Roche AG Financial Information
                8.4.2.4 F.Hoffmann-La Roche AG Product Positions/Portfolio
                8.4.2.5 F.Hoffmann-La Roche AG Key Developments
        8.4.3 Abbott Laboratories
                8.4.3.1 Business Description
                8.4.3.2 Abbott Laboratories Geographic Operations
                8.4.3.3 Abbott Laboratories Financial Information
                8.4.3.4 Abbott Laboratories Product Positions/Portfolio
                8.4.3.5 Abbott Laboratories Key Developments
        8.4.4 Becton
                8.4.4.1 Business Description
                8.4.4.2 Becton Geographic Operations
                8.4.4.3 Becton Financial Information
                8.4.4.4 Becton Product Positions/Portfolio
                8.4.4.5 Becton Key Developments
        8.4.5 Dickinson and Company
                8.4.5.1 Business Description
                8.4.5.2 Dickinson and Company Geographic Operations
                8.4.5.3 Dickinson and Company Financial Information
                8.4.5.4 Dickinson and Company Product Positions/Portfolio
                8.4.5.5 Dickinson and Company Key Developments
        8.4.6 bioMérieux SA
                8.4.6.1 Business Description
                8.4.6.2 bioMérieux SA Geographic Operations
                8.4.6.3 bioMérieux SA Financial Information
                8.4.6.4 bioMérieux SA Product Positions/Portfolio
                8.4.6.5 bioMérieux SA Key Developments
        8.4.7 Siemens
                8.4.7.1 Business Description
                8.4.7.2 Siemens Geographic Operations
                8.4.7.3 Siemens Financial Information
                8.4.7.4 Siemens Product Positions/Portfolio
                8.4.7.5 Siemens Key Developments
        8.4.8 Hologic Corporation
                8.4.8.1 Business Description
                8.4.8.2 Hologic Corporation Geographic Operations
                8.4.8.3 Hologic Corporation Financial Information
                8.4.8.4 Hologic Corporation Product Positions/Portfolio
                8.4.8.5 Hologic Corporation Key Developments
        8.4.9 Cepheid
                8.4.9.1 Business Description
                8.4.9.2 Cepheid Geographic Operations
                8.4.9.3 Cepheid Financial Information
                8.4.9.4 Cepheid Product Positions/Portfolio
                8.4.9.5 Cepheid Key Developments
        8.4.10 Hain Lifesciences GmbH
                8.4.10.1 Business Description
                8.4.10.2 Hain Lifesciences GmbH Geographic Operations
                8.4.10.3 Hain Lifesciences GmbH Financial Information
                8.4.10.4 Hain Lifesciences GmbH Product Positions/Portfolio
                8.4.10.5 Hain Lifesciences GmbH Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Tuberculosis Testing and Diagnostics Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Tuberculosis Testing and Diagnostics Market Revenue, By Test Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Tuberculosis Testing and Diagnostics Market Revenue, By End Use, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Tuberculosis Testing and Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Tuberculosis Testing and Diagnostics Market Revenue, By Test Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Tuberculosis Testing and Diagnostics Market Revenue, By End Use, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Tuberculosis Testing and Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Tuberculosis Testing and Diagnostics Market Revenue, By Test Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Tuberculosis Testing and Diagnostics Market Revenue, By End Use, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Tuberculosis Testing and Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Tuberculosis Testing and Diagnostics Market Revenue, By Test Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Tuberculosis Testing and Diagnostics Market Revenue, By End Use, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Tuberculosis Testing and Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Tuberculosis Testing and Diagnostics Market Revenue, By Test Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Tuberculosis Testing and Diagnostics Market Revenue, By End Use, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Tuberculosis Testing and Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Tuberculosis Testing and Diagnostics: Market Segmentation 
FIG. 2 Global Tuberculosis Testing and Diagnostics Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Tuberculosis Testing and Diagnostics Market, By Test Type, 2019 (US$ Mn) 
FIG. 5 Global Tuberculosis Testing and Diagnostics Market, By End Use, 2019 (US$ Mn) 
FIG. 6 Global Tuberculosis Testing and Diagnostics Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Tuberculosis Testing and Diagnostics Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Tuberculosis Testing and Diagnostics Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Tuberculosis Testing and Diagnostics Providers, 2019
FIG. 11 Global Tuberculosis Testing and Diagnostics Market Revenue Contribution, By Test Type, 2019 & 2028 (Value %) 
FIG. 12 Global Tuberculosis Testing and Diagnostics Market Revenue Contribution, By End Use, 2019 & 2028 (Value %) 
FIG. 13 Global Tuberculosis Testing and Diagnostics Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Tuberculosis Testing and Diagnostics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Tuberculosis Testing and Diagnostics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Tuberculosis Testing and Diagnostics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Tuberculosis Testing and Diagnostics Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Tuberculosis Testing and Diagnostics Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Tuberculosis Testing and Diagnostics market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Tuberculosis Testing and Diagnostics Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Tuberculosis Testing and Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  North America Tuberculosis Testing and Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  North America Tuberculosis Testing and Diagnostics Market Value, By Country, 2018 – 2028
TABLE  Europe Tuberculosis Testing and Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  Europe Tuberculosis Testing and Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  Europe Tuberculosis Testing and Diagnostics Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Tuberculosis Testing and Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Tuberculosis Testing and Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Tuberculosis Testing and Diagnostics Market Value, By Country, 2018 – 2028
TABLE  Latin America Tuberculosis Testing and Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Tuberculosis Testing and Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Tuberculosis Testing and Diagnostics Market Value, By Country, 2018 – 2028
TABLE  MEA Tuberculosis Testing and Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  MEA Tuberculosis Testing and Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  MEA Tuberculosis Testing and Diagnostics Market Value, By Country, 2018 – 2028
TABLE  Alere Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F.Hoffmann-La Roche AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Abbott Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Becton: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Dickinson and Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  bioMérieux SA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Siemens: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Hologic Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cepheid: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Hain Lifesciences GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Tuberculosis Testing and Diagnostics Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Tuberculosis Testing and Diagnostics Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Tuberculosis Testing and Diagnostics Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Tuberculosis Testing and Diagnostics Market, By Geography, 2019 (US$ Mn)
FIG.  Global Tuberculosis Testing and Diagnostics Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Tuberculosis Testing and Diagnostics Providers, 2016
FIG.  Global Tuberculosis Testing and Diagnostics Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Cytokine Detection Assay Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Nucleic Acid Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Detection of Latent Infection Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Diagnostic Laboratory Method Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Detection of Drug Resistance Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Tuberculosis Testing and Diagnostics Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Hospitals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Research Institutes and Academics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Reference Laboratories Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Tuberculosis Testing and Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Tuberculosis Testing and Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Tuberculosis Testing and Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Tuberculosis Testing and Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Tuberculosis Testing and Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Tuberculosis Testing and Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Tuberculosis Testing and Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Tuberculosis Testing and Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Tuberculosis Testing and Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Tuberculosis Testing and Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Tuberculosis Testing and Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Tuberculosis Testing and Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Tuberculosis Testing and Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Tuberculosis Testing and Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Tuberculosis Testing and Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Tuberculosis Testing and Diagnostics Market Value, 2018 – 2028, (US$ Mn)